1. Home
  2. HCWC vs NCNA Comparison

HCWC vs NCNA Comparison

Compare HCWC & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCWC
  • NCNA
  • Stock Information
  • Founded
  • HCWC N/A
  • NCNA 1997
  • Country
  • HCWC
  • NCNA United Kingdom
  • Employees
  • HCWC 450
  • NCNA N/A
  • Industry
  • HCWC
  • NCNA Biotechnology: Pharmaceutical Preparations
  • Sector
  • HCWC
  • NCNA Health Care
  • Exchange
  • HCWC NYSE
  • NCNA Nasdaq
  • Market Cap
  • HCWC 5.0M
  • NCNA 4.5M
  • IPO Year
  • HCWC N/A
  • NCNA 2017
  • Fundamental
  • Price
  • HCWC $0.42
  • NCNA $0.05
  • Analyst Decision
  • HCWC
  • NCNA Buy
  • Analyst Count
  • HCWC 0
  • NCNA 2
  • Target Price
  • HCWC N/A
  • NCNA $25.00
  • AVG Volume (30 Days)
  • HCWC N/A
  • NCNA 161.7M
  • Earning Date
  • HCWC N/A
  • NCNA 06-02-2025
  • Dividend Yield
  • HCWC N/A
  • NCNA N/A
  • EPS Growth
  • HCWC N/A
  • NCNA N/A
  • EPS
  • HCWC N/A
  • NCNA N/A
  • Revenue
  • HCWC N/A
  • NCNA N/A
  • Revenue This Year
  • HCWC N/A
  • NCNA N/A
  • Revenue Next Year
  • HCWC N/A
  • NCNA N/A
  • P/E Ratio
  • HCWC N/A
  • NCNA N/A
  • Revenue Growth
  • HCWC N/A
  • NCNA N/A
  • 52 Week Low
  • HCWC N/A
  • NCNA $0.03
  • 52 Week High
  • HCWC N/A
  • NCNA $10.79
  • Technical
  • Relative Strength Index (RSI)
  • HCWC N/A
  • NCNA 37.23
  • Support Level
  • HCWC N/A
  • NCNA $0.04
  • Resistance Level
  • HCWC N/A
  • NCNA $0.06
  • Average True Range (ATR)
  • HCWC 0.00
  • NCNA 0.01
  • MACD
  • HCWC 0.00
  • NCNA 0.03
  • Stochastic Oscillator
  • HCWC 0.00
  • NCNA 59.60

About HCWC HEALTHY CHOICE WELLNESS CORP

Healthy Choice Wellness Corp is a company engaged in providing consumers with healthier daily choices with respect to nutrition and other lifestyle alternatives. The company has one reportable segment which is natural and organic retail stores.

About NCNA NuCana plc

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.

Share on Social Networks: